IP Library Granted Patent US 9,226,989
Granted Patent B2
US 9,226,989 · App. 14/127,237 · Granted Jan 5, 2016

Film-forming composition, and use thereof for treating herpes

Inventor: Nathalie Derain (Prenois, FR)
Assignee: LABORATOIRES URGO
A61L26/0023A61K9/0014A61K9/7015A61K47/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,226,989
App. No.
14/127,237
Granted
Jan 5, 2016
Kind
B2
Abstract

The present invention relates to a topical film-forming composition including, in a pharmaceutically acceptable medium: 5 to 30 wt % of ethyl cellulose; 0.1 to 10 wt % of an auxiliary film-forming agent; 0.1 to 20 wt % of one or more triacids, at least one of which is boric acid; and 60 to 95 wt % of an organic solvent, the percentages being expressed by weight relative to the total weight of the composition. The invention also relates to the use of such a composition in a method for treating herpes, in particular herpes labialis.

Claims (24)

1. A topical film-forming composition comprising, in a pharmaceutically acceptable medium:

5% to 30% by weight of ethylcellulose;

0.1% to 20% by weight of an auxiliary film-forming agent;

0.1% to 5% by weight of one or more triacids, at least one of which is boric acid; and

60% to 95% by weight of an organic solvent,

the percentages being expressed by weight, relative to the total weight of the composition.

2. The composition of claim 1 , wherein the ethylcellulose is present in a content ranging from 8% to 20% by weight relative to the total weight of the composition.

3. The composition of claim 2 , wherein the ethylcellulose is present in a content ranging from 8% to 15% by weight, relative to the total weight of the composition.

4. The composition of claim 1 , wherein the auxiliary film-forming agent is chosen from oxyethylenated derivatives.

5. The composition of claim 4 , wherein the oxyethylenated derivative is an oxyethylenated oil.

6. The composition of claim 5 , wherein said oxyethylenated oil is vegetable oil.

7. The composition of claim 1 , wherein the auxiliary film-forming agent is present in a content ranging from 2% to 12% by weight, relative to the total weight of the composition.

8. The composition as of claim 1 , wherein the triacid comprises a mixture of boric acid and citric acid.

9. The composition of claim 8 wherein the mixture of boric acid and citric acid is in a weight ratio of between 1:2 and 2:1.

10. The composition of claim 1 , wherein the organic solvent is chosen from alcohols which are liquid at ambient temperature.

11. The composition of claim 10 , wherein the alcohol is selected from the group consisting of ethanol, isopropanol, diacetone alcohol, 2 butoxyethanol, cyclohexanol, and mixtures thereof.

12. The composition of claim 11 , wherein the alcohol is ethanol.

13. The composition as of claim 1 , wherein the organic solvent represents 65% to 85% by weight, relative to the total weight of the composition.

14. The composition of claim 1 , wherein said composition further comprises water.

15. The composition of claim 14 , wherein said water content is present ranging from 1% to 20% by weight of said composition.

16. The composition of claim 15 wherein said water content is present ranging from 5% to 15% by weight of said composition.

17. The composition of claim 1 , wherein it does not contain any additional pharmaceutically active agent for the treatment of herpes.

18. A method for treating herpes, comprising the application of a composition as of claim 1 .

19. A method according to claim 18 wherein treating herpes is herpes labialis.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2014
From: DERAIN, NATHALIE
To: LABORATOIRES URGO
Reel/Frame 032608/0041 →
Priority Claims (1)
FR 11 55493 · Jun 22, 2011 · national
Continuity (1)
Related Publication 20140130711A1 · May 15, 2014